FLEXION THERAPEUTICS INC has a total of 48 patent applications. It decreased the IP activity by 44.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are SHIHUIDA PHARMACEUTICALS GROUP JILIN LTD, ATAJJE INC and ACCELALOX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | Australia | 5 | |
#5 | Japan | 4 | |
#6 | Canada | 3 | |
#7 | Singapore | 3 | |
#8 | Republic of Korea | 2 | |
#9 | Argentina | 1 | |
#10 | Brazil | 1 | |
#11 | Chile | 1 | |
#12 | China | 1 | |
#13 | Colombia | 1 | |
#14 | Israel | 1 | |
#15 | New Zealand | 1 | |
#16 | Taiwan | 1 | |
#17 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Bodick Neil | 42 |
#2 | Blanks Robert C | 28 |
#3 | Moran Mark | 28 |
#4 | Kumar Anjali | 28 |
#5 | Clayman Michael D | 27 |
#6 | Jackson Derek | 6 |
#7 | Neil Bodick | 5 |
#8 | Joshi Ujjwal | 5 |
#9 | Anjali Kumar | 4 |
#10 | Michael D Clayman | 4 |
Publication | Filing date | Title |
---|---|---|
WO2021055860A1 | Effective dosages of an adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis in humans, and compositions comprising the same | |
WO2021050470A1 | Sustained release thermosetting gels comprising sodium channel blockers and the methods of making the same | |
US2020009156A1 | Fluticasone extended-release formulations and methods of use thereof | |
WO2018112408A1 | Fluticasone formulations and methods of use thereof | |
EP3429594A1 | Triamcinolone acetonide formulations for joint pain in diabetics | |
US2017100411A1 | Corticosteroid formulations for maintaining corticosteroid synovial fluid concentrations | |
AU2015268647A1 | Corticosteroids for the Treatment of Joint Pain | |
WO2014153384A1 | Corticosteroid formulations for the treatment of joint pain and methods of use thereof | |
EP2739287A1 | Corticosteroids for the treatment of joint pain | |
CN107669640A | For treating arthralgic corticosteroid |